Failure to Reevaluate

February 2011
Pulmonary Reviews;Feb2011, Vol. 16 Issue 2, p22
Case Study
The article describes a clinical case study of a 61-year-old woman who became infected with methicillin-resistant staphylococcus aureus (MRSA) while undergoing chemotherapy for non-small cell lung cancer at a community hospital. The patient suffered renal failure due to subsequent vancomycin therapy for MRSA infection. This article explains the effects of vancomycin toxicity as it relates to detection of acute kidney injury (AKI). It recommends the need for proactive input from pharmacists in order to prevent drug-induced toxicity.


Related Articles

  • Emergence of Methicillin-Resistant Staphylococcus aureus with Intermediate Glycopeptide Resistance: Clinical Significance and Treatment Options. Rybak, M.J.; Akins, R.L. // Drugs;Jan2001, Vol. 61 Issue 1, p1 

    Methicillin-resistant Staphylococcus aureus is a pathogen that is associated with serious infections that pose a significant risk of morbidity and mortality because of their multidrug resistant nature. Until recently, therapeutic options were limited to vancomycin, making the use of this drug...

  • Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. S. Kohno; K. Yamaguchi; N. Aikawa; Y. Sumiyama; S. Odagiri; N. Aoki; Y. Niki; S. Watanabe; M. Furue; T. Ito; R. Croos-Dabrera; K. J. Tack // Journal of Antimicrobial Chemotherapy (JAC);Dec2007, Vol. 60 Issue 6, p1361 

    Objectives To compare the efficacy and safety of linezolid and vancomycin for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Japan. Methods Patients with nosocomial pneumonia, complicated skin and soft-tissue infections or sepsis caused by MRSA were randomized...

  • Alternatives for MRSA Treatment in the Pediatric Patient. Lopez, Ibis D. // Orthopedics;Oct2004, Vol. 27 Issue 10, p1051 

    The article offers alternatives for methicillin resistant Staphylococcus aureus treatment in the pediatric patient. One alternative is vancomycin. The effectiveness of the drug is assessed. Moreover, this article discusses the safety of linezolid in treating Staphylococcus aureus infections.

  • Reply to Parra-Ruiz. van Hal, Sebastiaan J.; Fowler, Vance G. // Clinical Infectious Diseases;Oct2013, Vol. 57 Issue 8, p1219 

    A reply to the letter to the editor by the authors about their article "Is it time to replace vancomycin in the treatment of methicillin-reistant Staphylococcus aureus infections?" in the 2013 issue is presented.

  • IDSA Guidelines on the Treatment of MRSA Infections in Adults and Children. LAMBERT, MARA // American Family Physician;8/15/2011, Vol. 84 Issue 4, p455 

    The article discusses the evidence-based guidelines released by the Infectious Diseases Society of America (IDSA) on the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. It cites oral antibiotic options to treat skin and soft-tissue infections in patients with...

  • Methicillin resistant Staphylococcus aureus nasal colonization among secondary school students at Duhok City-Iraq. Habeeb, Ary; Hussein, Nawfal R.; Assafi, Mahde S.; Al-Dabbagh, Samim A. // Journal of Microbiology & Infectious Diseases;Jun2014, Vol. 4 Issue 2, p59 

    Objective: Methicillin-resistant Staphylococcus aureus (MRSA) widely distributed in hospitals around the world. There is strong relationship between disease development and S. aureus nasal carriage. The aim of this study was to evaluate the prevalence and epidemiology of nasal colonization with...

  • Prevalence and Antibiotic Sensitivity Pattern of Methicillin- Resistant- Staphylococcus aureus in Kathmandu Medical College -Teaching Hospital. Pandey, S.; Raza, M. S.; Bhatta, C. P. // Journal of Institute of Medicine;Apr2012, Vol. 34 Issue 1, p13 

    Introduction: Staphylococcus aureus is found to be a major source of community as well as hospital acquired infection. Staphylococcal isolates from tertiary care hospital are found to be resistant to commonly used antimicrobial agents. Methicillin resistant S. aureus(MRSA) with intrinsically...

  • The diminishing value of vancomycin. Bush, Larry M.; Kaye, Donald // Infectious Disease News;Jul2014, Vol. 27 Issue 7, p26 

    The article examines the diminishing value of vancomycin as a treatment for Staphylococcus aureus-related infections and diseases.

  • Trend of vancomycin susceptibility of staphylococci at a level 1 trauma centre of India. Jain, Neetu; Mathur, Purva; Misra, M. C. // Indian Journal of Medical Research;Dec2013, Vol. 138 Issue 6, p1022 

    A letter to the editor about vancomycin susceptibility of coagulase-negative staphylococci (CoNS) is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics